Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,427 | 20,408 | 18,089 | 16,160 | 14,949 |
| Marketable Securities | N/A | N/A | N/A | 10,835 | 18,576 |
| Receivables | 3,026 | 344 | 973 | 15,600 | 15,402 |
| Other current assets | 126 | 284 | 567 | 836 | 1,027 |
| TOTAL | $27,935 | $21,438 | $19,999 | $43,602 | $50,183 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 4 | 7 | 11 | 15 |
| TOTAL | $N/A | $4 | $7 | $11 | $15 |
| Total Assets | $27,935 | $21,442 | $20,006 | $43,613 | $50,198 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,499 | 2,983 | 2,822 | 3,380 | 2,436 |
| Accrued Expenses | 8,952 | 10,443 | 8,675 | 9,299 | 10,779 |
| Other current liabilities | 754 | 463 | 1,940 | 17,821 | 18,514 |
| TOTAL | $18,117 | $19,487 | $17,167 | $32,428 | $32,124 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,779 | 14,621 | 16,342 | 18,002 | 18,477 |
| Deferred Revenues | 1,658 | 1,342 | 1,342 | 1,342 | 395 |
| Other Non-Current Liabilities | 17,464 | 44,312 | 28,193 | 39,343 | 39,058 |
| TOTAL | $37,045 | $62,347 | $48,284 | $61,430 | $58,837 |
| Total Liabilities | $55,162 | $81,834 | $65,451 | $93,858 | $90,961 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,900 | 12,535 | 11,903 | 11,887 | 11,887 |
| Common Shares | 126 | 121 | 119 | 119 | 118 |
| Retained earnings | -595,009 | -616,827 | -594,664 | -598,668 | -586,969 |
| Other shareholders' equity | 1 | 0 | 1 | -4 | -4 |
| TOTAL | $-27,227 | $-60,392 | $-45,445 | $-50,245 | $-40,763 |
| Total Liabilities And Equity | $27,935 | $21,442 | $20,006 | $43,613 | $50,198 |